Lakeside Holding Limited

Lakeside Holding Limited

LSH
Lakeside Holding LimitedUS flagNASDAQ Capital Market
0.62
USD
-0.03
- -
5.84MMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.6
2.15
3.05
- -
1.73
Basic EPS, GAAP
- -
0.16
-0.04
- -
-0.6
Free Cash Flow per Basic Share
0.02
- -
-0.01
- -
-0.16
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
0.14
- -
- -
-0.58
Tangible Book Value per Share
0.02
0.14
0.11
- -
0.05
Basic Weighted Avg Shares
6
6
6
8
8
Sales/Revenue/Turnover
10
13
18
- -
13
Operating Margin (%)
-1.21
1.93
-2.47
- -
-30.61
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
1
- -
- -
-5
Effective Tax Rate (%)
- -
6.45
- -
- -
- -
Profit Margin (%)
-0.03
7.64
-1.23
- -
-34.8
Working Capital
-1
- -
-2
- -
-2
LT Debt
3
2
3
- -
2
Total Equity
- -
1
1
- -
1
Return on Invested Capital (%)
- -
5.82
- -
- -
- -
Return on Capital (%)
- -
28.46
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'25
ST Debt
2
3
4
LT Borrowings
- -
- -
- -
LT Finance Leases
3
2
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
8
8
8
Market Capitalization
24
18
8

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'25
Total Current Assets
6
4
5
Cash, Cash Equivalents & STI
3
1
1
Accounts Receivable, Net
2
2
2
Inventories
- -
- -
- -
Total Current Liabilities
4
5
7
Payables & Accruals
2
3
3
ST Debt
2
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
4
5
4
5
18
2025
4
4
- -
- -
- -
2026
6
7
1
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.04
0.01
- -
- -
-0.04
2025
-0.18
-0.26
-0.14
- -
- -
2026
-0.09
-0.08
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Henry Liu
Full Time Employees
50
Sector
Industrials
Industry
Integrated Freight & Logistics
Address
1475 Thorndale Avenue Itasca IL United States of America 60143
IPO Date
Jun 28, 2024
Business
Lakeside Holding Limited Lakeside Holding Limited (NASDAQ: LSH) is a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market, including China and South Korea; it offers customized cross-border ocean freight and airfreight solutions, including freight consolidation and forwarding, customs clearance, container unloading, warehousing and distribution, unpacking and packing, ground transportation, and pick-and-pack fulfillment services, primarily through its American Bear Logistics brand with operations in Chicago, Dallas, Los Angeles, and New York; following its acquisition of Hupan Pharmaceutical (Hubei) Co. in late 2024 for $0.6 million, it has expanded into pharmaceutical logistics and distribution in China, securing partnerships such as distribution agreements with Kelun Pharmaceutical in January 2025 and a $1.5 million sales agreement with Sinopharm Holding Hubei New Special Medicine Co., Ltd. in November 2024; the company, founded in 2018 and headquartered in Itasca, Illinois, serves Asia- and U.S.-based logistics firms supporting e-commerce platforms, social commerce, and manufacturers transporting consumer and industrial goods into the U.S.

Company News

APIChat
  • Lakeside (NASDAQ:LSH) and Jungheinrich (OTCMKTS:JGHAF) Critical Analysis

  • Lakeside (NASDAQ:LSH) Trading Down 2.9% – Time to Sell?

  • Critical Survey: Lakeside (NASDAQ:LSH) versus Shengfeng Development (NASDAQ:SFWL)

  • Financial Review: Callan JMB (NASDAQ:CJMB) versus Lakeside (NASDAQ:LSH)

  • Lakeside (NASDAQ:LSH) and Universal Logistics (NASDAQ:ULH) Head to Head Analysis

  • Lakeside (NASDAQ:LSH) Trading Down 1.8% – Here’s What Happened

  • Lakeside Announces Fiscal 2025 Third Quarter and Nine-Month Results

  • LAKESIDE HOLDING ANNOUNCES A CONVERTIBLE DEBT FINANCING OF UP TO $4.5 MILLION

  • Lakeside Announces Fiscal 2025 Second Quarter and Six-Month Results

  • Lakeside Secures New Distribution Agreements with Kelun Pharmaceutical

  • Lakeside Partners with Huiyu Pharmaceutical to Revolutionize Oncology Drug Distribution

  • Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

  • Lakeside Holding to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

  • Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts

  • LAKESIDE HOLDING PROVIDES FIRST QUARTER OF FISCAL YEAR 2025 RESULTS

  • Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd.

  • Lakeside Holding Reports Impressive 42% Revenue Growth for Fiscal Year 2024

  • LAKESIDE HOLDING EXPANDS DALLAS-FORT WORTH OPERATIONS WITH NEW OFFICE AND WAREHOUSE LEASE

  • LAKESIDE HOLDING LAUNCHES NEW PICK & PACK FULFILLMENT SERVICE ACROSS KEY U.S. HUBS FOR LONGSTANDING CHINA LOGISTICS PARTNER

  • Update: Lakeside Holding Partners With Leading Global Social Media and E-Commerce Platform to Streamline Cross-Border Fulfillment